Lisanti Capital Growth, LLC Axogen, Inc. Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$17.09 - $38.25 $790,583 - $1.77 Million	-46,260 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$34.05 - $55.9 $1.05 Million - $1.72 Million	-30,755 Reduced 39.93%	46,260 $1.71 Million
Q2 2018 Aug 13, 2018	BUY	$36.15 - $52.5 $1.29 Million - $1.87 Million	35,565 Added 85.8%	77,015 $3.87 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $1.01 Million - $1.67 Million	41,450 New	41,450 $1.51 Million

132

35.8M

79.1K

500

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $592M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.